FLPIM
BIVV

F.L. Putnam Investment Management’s Bioverativ Inc. Common Stock BIVV Stock Holding History

F.L. Putnam Investment Management’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-11,228
Closed -$605K – 251
2017
Q4 		$605K Buy
11,228
+11
+0.1% +$602 0.06% 169
2017
Q3 		$640K Buy
+11,217
New +$657K 0.06% 162
2017
Q1 		$411K Buy
+7,548
New +$372K 0.04% 178

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

F.L. Putnam Investment Management's BIVV Position: Q1 2018 in Review

F.L. Putnam Investment Management sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 11,228 shares — an estimated $605K sold.

F.L. Putnam Investment Management first reported a position in BIVV in Q1 2017 and held it in 3 quarters. The position peaked at $640K in Q3 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • F.L. Putnam Investment Management reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • F.L. Putnam Investment Management sold 11,228 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $605K.
  • F.L. Putnam Investment Management first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 3 quarters.
  • F.L. Putnam Investment Management's Bioverativ Inc. Common Stock position peaked at $640K in Q3 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on F.L. Putnam Investment Management's 13F filing for Q1 2018, filed 1 May 2018.